The 8th Annual Meeting of the Radiogenomics Consortium will take place on 13 July, 2016 in Maastricht, the Netherlands and is hosted by MAASTRO-Clinic.
The Radiogenomics Consortium was established in November 2009. The scientific hypothesis underlying the development of the consortium is that a cancer patient's likelihood of developing toxicity to radiation therapy is influenced by common genetic variations, such as single nucleotide polymorphisms (SNPs). One of the research projects that resulted from the Radiogenomics consortium is REQUITE. Many of the researchers involved in the REQUITE project are also part of the Radiogenomics consortium. A good reason to combine both yearly meetings at one moment of the year in the same venue, giving the involved people the opportunity to attend both meetings.